|
EP2153834A2
|
|
Extended release pharmaceutical compositions comprising quetiapine salts
|
|
WO2010015623A1
|
|
Process for the preparation of endothelin receptor antagonists
|
|
EP2291177A2
|
|
Stable pharmaceutical compositions and their processes for preparation suitable for industrial scale
|
|
WO2009098271A1
|
|
Process for the purification of montelukast by the preparation of acid addition salts and tert-amylamine salt
|
|
US2010029938A1
|
|
Process for the preparation of an antibacterial quinolone compound
|
|
EP2022789A1
|
|
Process for the preparation of a gastric acid secretion inhibitor
|
|
WO2008012346A1
|
|
Extended release pharmaceutical formulation of metoprolol and process for its preparation
|
|
EP2004609A2
|
|
Process for preparing a leukotriene antagonist
|
|
EP1939206A1
|
|
Process for the preparation of an antibacterial quinolone compound
|
|
US2008281097A1
|
|
Process for Preparing an Angiotensin II Receptor Antagonist
|
